Eleven Biotherapeutics (EBIO) Reports Q1 Loss of $0.33/Share

August 12, 2016 8:50 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Eleven Biotherapeutics (NASDAQ: EBIO) reported Q1 EPS of ($0.33), versus ($0.36) reported last year. Revenue for the quarter came in at $277 thousand, versus $114 thousand reported last year.

For earnings history and earnings-related data on Eleven Biotherapeutics (EBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment